NeetaDPandit-TaskarMD

Clinical Trials

• Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 Start of enrollment: 2005 Jul 06

  Completed

  Phase 1

• Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59) Start of enrollment: 1977 Jul 01

  Completed

  Phase 1

• Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. Start of enrollment: 2004 Jun 01

  Completed

  Early Phase 1

• Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer Start of enrollment: 2013 Aug 01

  Completed

  Phase 1, Phase 2

• Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma Start of enrollment: 2021 Feb 02

  Recruiting

  Early Phase 1

• 89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL) Start of enrollment: 2020 Sep 11

  Active, not recruiting

  Early Phase 1

• Open-Label Study of 18F-mFBG for Imaging Neuroblastoma Start of enrollment: 2021 Nov 18

  Active, not recruiting

  Phase 3

  Roles: Contact

• CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma Start of enrollment: 2022 Mar 11

  Recruiting

  Phase 2

  Roles: Contact

• Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma Start of enrollment: 2006 May 01

  Recruiting

  Phase 2

  Roles: Contact

• Study of a New Technique for Imaging Pancreatic Cancer Start of enrollment: 2021 May 10

  Active, not recruiting

  Phase 1

  Roles: Contact, Principal Investigator

• Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer Start of enrollment: 2022 Feb 16

  Recruiting

  Phase 2

  Roles: Contact

• Safety and Targeting of Anti-hk2 Antibody in mCRPC Start of enrollment: 2019 Sep 18

  Terminated

  Early Phase 1

  Roles: Contact

• PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 Start of enrollment: 2023 Feb 10

  Recruiting

  Phase 1

  Roles: Contact, Principal Investigator

• Join now to see all